Fairvalue-Calculator Fairvalue-Calculator
EN DE

Kuangli Bio-Tech Holdings (6431) Fair Value & Analysis

Consumer Defensive · TW · Market cap 1.8B TWD

Price18.25 TWD
Fair Value17.78 TWD
Upside-2.6%
Quality95/100
Evidence: Low Range 13.34 TWD – 22.23 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Kuangli Bio-Tech Holdings (6431) currently trades at 18.25 TWD, while our model-based Fair Value estimate is 17.78 TWD — implying the stock looks roughly 2.6% overvalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Kuangli Bio-Tech Holdings Co., Ltd. manufactures and sells panels for cover lens used in various electronic products in Taiwan and China. The company's products are used in mobile phone, PDA, instrument panels, digital camera windows, medical equipment, etc. It also engages in research and development, manufacturing, and sale of related biotech products, such as cosmetic, skin care, and health food products. The company was formerly known as Kuangli Photoelectric Technology Co., Ltd. Kuangli Bio-Tech Holdings Co., Ltd. was founded in 2012 and is based in Grand Cayman, Cayman Islands.

Open the full interactive analysis →

Similar stocks

The Procter & Gamble Company (PG) -33% L'Oréal S.A (LRLCF) -36% Unilever PLC (UNLYF) -22% Colgate-Palmolive Company (CPA) -54% Hindustan Unilever Limited (HINDUNILVR) -54% Reckitt Benckiser Group (RBGLY) +41%

Frequently asked questions

Is Kuangli Bio-Tech Holdings (6431) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 17.78 TWD versus a price of 18.25 TWD — about −3% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6431?
Our 21-model fair value for Kuangli Bio-Tech Holdings is 17.78 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 18.25 TWD.
What is the quality score of 6431?
Kuangli Bio-Tech Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.